InvestorsObserver
×
News Home

Is Merck & Co Inc (MRK) a Bad Choice in Drug Manufacturers - General Thursday?

Thursday, March 28, 2024 11:10 AM | InvestorsObserver Analysts

Mentioned in this article

Is Merck & Co Inc (MRK) a Bad Choice in Drug Manufacturers - General Thursday?

The 62 rating InvestorsObserver gives to Merck & Co Inc (MRK) stock puts it near the top of the Drug Manufacturers - General industry. In addition to scoring higher than 88 percent of stocks in the Drug Manufacturers - General industry, MRK’s 62 overall rating means the stock scores better than 62 percent of all stocks.

Overall Score - 62
MRK has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on MRK!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 62 would rank higher than 62 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Merck & Co Inc Stock Today?

Merck & Co Inc (MRK) stock has fallen -0.09% while the S&P 500 is up 0.07% as of 11:09 AM on Thursday, Mar 28. MRK has fallen -$0.12 from the previous closing price of $131.75 on volume of 1,628,935 shares. Over the past year the S&P 500 has gained 30.40% while MRK is up 25.46%. MRK earned $0.14 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 918.71. Click Here to get the full Stock Report for Merck & Co Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App